medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2022, Number 01

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (01)

Procedures from the Iberoamerican Research Network and the Mexican Federation of Obstetrics and Gynecology Colleges for the care of SARS-CoV-2 and Pregnancy

Medina-Jiménez V, Ruiz-Marines LA, Bermúdez-Rojas ML, Herrera-Venegas CA, Pérez-Nieto OR, Zamarrón-López EI, Deloya-Tomás E, Sosa-Bolio JA, Mendoza-Carrera CE, Garduño-García G, Ramírez-Abarca TG, Sánchez-Rodríguez MÁ, Iyune-Cojab E, León-Lara KX, Rubio-Cacique MH, Martínez-Portilla RJ

Language: Spanish
References: 148
Page: 32-72
PDF size: 498.49 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Torres-Torres J; Robles-Morales R; Robles-Elias F; Espino y Sosa S; Aguilar-Torres C; Hernandez-Nieto C; Gurrola-Ochoa R; Rojas Zepeda L SMR. Protocolo de Iberoamerican Research Network y la Federacion Mexicana de Colegios de Obstetricia y Ginecologia para SARS CoV-2 y Embarazo.Actualizacion de la evidencia en: control prenatal, tratamiento, prevencion y vacunacion 2021. doi:10.17605/OSF.IO/6YT2G

  2. Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):e759-e72. doi:10.1016/S2214-109X(21)00079-6.

  3. Townsend R, Chmielewska B, Barratt I, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Global changes in maternity care provision during the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 2021;37:100947. doi:10.1016/j.eclinm.2021.100947

  4. World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2021. https://covid19.who.int/.

  5. Comité Nacional Para la Vigilancia Epidemiológica Gobierno de México. Aviso Epidemiologico: COVID-19 durante el Embarazo 2021. https://omm.org.mx/wp-content/uploads/2021/08/Aviso-Epidemiologico-Embarazo-COVID4-agosto-2021-final.pdf.

  6. Secretaría de Salud Gobierno de México. Informe Semanal de Notificacion Inmediata de Muerte Materna 2021. https://www.gob.mx/cms/uploads/attachment/file/666356/MM_2021_SE35.pdf.

  7. Ellington SSP, Tong V, Woodworth K, Galang R, Zambrano L, et al. Characteristics of Women of Reproductive Age with Laboratory Confirmed SARS CoV-2 infection by Pregnancy Status-United States. MMMWR Morb Mortal Wkly Rep. 2020;69:769-75. doi:10.15585/mmwr.mm6925a1

  8. Mendez-Dominguez N, Santos-Zaldivar K, Gomez-Carro S, Datta-Banik S, Carrillo G. Maternal mortality during the COVID-19 pandemic in Mexico: a preliminary analysis during the first year. BMC Public Health. 2021;21(1):1297. doi:10.1186/s12889-021-11325-3

  9. Mullins E, Hudak ML, Banerjee J, Getzlaff T, Townson J, Barnette K, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021;57(4):573-81. doi:10.1002/uog.23619

  10. Vale A FA, Guzen F, Pinheiro F, de Azevedo E, Cobucci R. Susceptibility to COVID-19 in Pregnancy, Labor, and Postpartum Period: Immune System, Vertical Transmission, and Breastfeeding. Front Glob Womens Health. 2021;2:1-16. doi:10.3389/fgwh.2021.602572

  11. Martinez-Portilla R SA, Chatzakis C, Torres-Torres J, Espino y Sosa S, Sandoval-Mandujano K, Castro-Bernabe D, Medina-Jimenez V, Monarrez-Martin J, Figueras F, Poon L. Pregnant women with SARS-CoV-2 infection are at higher risk of death and severe pneumonia: propensity score- matched analysis of a nationwide prospective cohort study (COV19Mx). Ultrasound Obstet Gynecol. 2020. doi:10.1002/uog.23575

  12. Martínez-Portilla R SA, Torres-Torres J, Chatzakis C, Hawkins-Villareal A, Villafan-Bernal R, et al. . Risk factors for mortality in pregnant women with SARS-CoV-2 infection. medRxiv. 2020. https://doi.org/10.1101/2020.05.31.20107276

  13. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi:10.1136/bmj.m3320

  14. Karasek D BR, McLemore M, Bell F, Blebu B, Casey J. The association of COVID-19 infection in pregnancy with preterm birth: A retrospective cohort study in California. The Lancet Regional Health-Americas. 2021. doi:10.1016/j.lana.2021.100027

  15. Zarrilli G AV, Businello G, Sbaraglia M, Traverso G, Fortarezza F, et al. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci. 2021;22:1-11. doi:10.3390/ijms22020974

  16. Madden N EU, Polin M, Bejerano S, Gyamfi-Bannerman C, Booker W. COVID-19 and new hypertensive disease in pregnancy. Am J Obstet Gynecol. 2021;224:S23-S4.

  17. Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, Garcia-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021;225(3):289 e1- e17. doi:10.1016/j.ajog.2021.05.014

  18. Kumar R YC, Utami N, Masand R, Asrani R, Patel S. SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review. Journal of Infection and Public Health. 2021;14. doi:10.1016/j.jiph.2021.04.005

  19. Royal College of Obstetricians & Gynaecologists. Coronavirus (COVID-19) Infection in Pregnancy 2021. https://www.rcog.org.uk/globalassets/documents/guidelines/2021-08-25-coronavirus-covid-19-infection-in-pregnancy-v14.pdf.

  20. Lapinsky SE, Adhikari NK. COVID-19, variants of concern and pregnancy outcome. Obstet Med. 2021;14(2):65-6. doi:10.1177/1753495X211028499

  21. Cruz-Lemini M, Ferriols Perez E, de la Cruz Conty ML, Cano Aguilar A, Encinas Pardilla MB, Prats Rodriguez P, et al. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women. Viruses. 2021;13(1). doi:10.3390/v13010112

  22. Cardona-Perez JAV-MI, Huelguera-Repetto A, Acevedo-Gallegos S, Rodriguez-Bosch M, Aguinaga-Rios M, et al. Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico. PLoS One. 2021. doi:10.1371/journal.pone.0249584

  23. Ciapponi A, Bardach A, Comande D, Berrueta M, Argento FJ, Rodriguez Cairoli F, et al. COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes. PLoS One. 2021;16(6):e0253974. doi:10.1371/journal.pone.0253974

  24. Secretaría de Salud Gobierno de México. Lineamiento para la prevención y mitigación de COVID-19 en la atención del embarazo, parto, puerperio y de la persona recién nacida. 2021. https://coronavirus.gob.mx/wp-content/uploads/2021/05/LineamientoSMP_COVID19Actualizacion_110521.pdf.

  25. Dowswell T, Carroli G, Duley L, Gates S, Gulmezoglu AM, Khan-Neelofur D, et al. Alternative versus standard packages of antenatal care for low-risk pregnancy. Cochrane Database Syst Rev. 2015(7):CD000934. doi:10.1002/14651858.CD000934.pub3

  26. Relph S, Thangaratinam S. Maternal medicine in the COVID era. Best Pract Res Clin Obstet Gynaecol. 2021;73:113-24. doi:10.1016/j.bpobgyn.2021.03.003

  27. Aziz A, Fuchs K, Nhan-Chang CL, Zork N, Friedman AM, Simpson LL. Adaptation of prenatal care and ultrasound. Semin Perinatol. 2020;44(7):151278. doi:10.1016/j.semperi.2020.151278

  28. Equide Unicef. Resultados de la “Encuesta de seguimiento de los efectos del covid-19 en el bienestar de los hogares mexicanos” marzo 2021. http://www.equide.org/wp-content/uploads/2021/06/Comunicado_Encovid_21mar.pdf.

  29. Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynaecol Obstet. 2020;149(3):273-86. doi:10.1002/ijgo.13156

  30. Deprest J, Choolani M, Chervenak F, Farmer D, Lagrou K, Lopriore E, et al. Fetal Diagnosis and Therapy during the COVID-19 Pandemic: Guidance on Behalf of the International Fetal Medicine and Surgery Society. Fetal Diagn Ther. 2020;47(9):689-98. doi:10.1159/000508254

  31. Janik E, Bartos M, Niemcewicz M, Gorniak L, Bijak M. SARS-CoV-2: Outline, Prevention, and Decontamination. Pathogens. 2021;10(2). doi:10.3390/pathogens10020114

  32. WHO. The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline. 2021. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

  33. Chervenak FA, McCullough LB, Bornstein E, Johnson L, Katz A, McLeod-Sordjan R, et al. Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients. Am J Obstet Gynecol. 2021. doi:10.1016/j.ajog.2021.01.027

  34. Posicionamiento de la FEMECOG e Iberoamerican Research Network sobre vacunación contra SARS-CoV-2 durante la gestación: actualización 2021. https://omm.org.mx/wp-content/uploads/2021/05/Vacunacio%CC%81n-Posicionamiento-FEMECOG.pdf]

  35. Skjefte M NM, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski D, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021;36:197-211. doi:10.1007/s10654-021-00728-6

  36. Shimabukuro T KS, Myers T, Moro P, Oduyebo T, Panagiotakopoulus L, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N Engl J Med. 2021;384:2273-82. doi:10.1056/NEJMoa2104983

  37. Blakeway H PS, Kalafat E, Heath P, Ladhani S, Le-Doare K, et al. COVID-19 Vaccination During Pregnancy: Coverage and Safety. Am J Obstet Gynecol. 2021:1-36. doi:10.1016/j.ajog.2021.08.007

  38. Gray K BE, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225:e1-e17. doi:10.1016/j.ajog.2021.03.023.

  39. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020;222(6):521-31. https://doi.org/10.1016/j.ajog.2020.03.021

  40. Secretaría de Salud Gobierno de México. Actualizacion de la Definicion Operacional de Caso Sospechoso de Enfermedad Respiratoria Viral 2020. https://www.gob.mx/cms/uploads/attachment/file/573732/Comunicado_Oficial_DOC_sospechoso_ERV_240820.pdf.

  41. CDC. Operational Considerations for Adapting a Contact Tracing Program to Respond to the COVID-19 Pandemic in non-US Settings 2021. https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/operational-considerations-contact-tracing.html.

  42. Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020;55(5):700-8. doi:10.1002/uog.22013

  43. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3).

  44. Secretaría de Salud Gobierno de México. Lineamiento Estandarizado para la Vigilancia Epidemiológica y por Laboratorio de la enfermedad respiratoria viral 2021. https://www.gob.mx/salud/documentos/lineamiento-estandarizado-para-la-vigilancia-epidemiologica-y-por-laboratorio-de-la-enfermedad-respiratoria-viral]

  45. Secretaría de Salud Gobierno de México. Comunicado emergente sobre el uso de pruebas para la deteccion de antigeno SARS-CoV-2 en Mexico 2020. https://coronavirus.gob.mx/wp-content/uploads/2020/11 Prueba_antigenica_COVID_11Nov2020.pdf.

  46. Rottenstreich A ZG, Kabiri D, Porat S, Sompolinsky Y, Reubinoff B, et al. Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery. Am J Obstet Gynecol. 2021. doi:10.1016/j.ajog.2021.01.002

  47. Kucirka LM, Norton A, Sheffield JS. Severity of COVID-19 in pregnancy: A review of current evidence. Am J Reprod Immunol. 2020;84(5):e13332. doi:10.1111/aji.13332

  48. Diaz-Corvillon P, Monckeberg M, Barros A, Illanes SE, Soldati A, Nien JK, et al. Routine screening for SARS CoV-2 in unselected pregnant women at delivery. PLoS One. 2020;15(9):e0239887. doi: 10.1371/journal.pone.0239887

  49. ACOG. Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e6. doi:10.1097/AOG.0000000000002355.

  50. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020;296(2):E32-E40. doi:10.1148/radiol.2020200642

  51. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425-34. doi:10.1016/S1473-3099(20)30086-4

  52. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. doi:10.1056/NEJMoa2002032

  53. Li W, Liu H, Cheng F, Li Y, Li S, Yan J. Artificial intelligence applications for oncological positron emission tomography imaging. Eur J Radiol. 2021;134:109448. doi:10.1016/j.ejrad.2020.109448

  54. Inchingolo R, Smargiassi A, Moro F, Buonsenso D, Salvi S, Del Giacomo P, et al. The diagnosis of pneumonia in a pregnant woman with coronavirus disease 2019 using maternal lung ultrasound. Am J Obstet Gynecol. 2020;223(1):9-11. doi:10.1016/j.ajog.2020.04.020

  55. Inchingolo R SA, Mormile F, Marra R, De Carolis S, Lanzone A, et al. Look at the lung: Can chest ultrasonography be useful in pregancy? . Multidiscip Respir Med. 2014;9:1-5. doi:10.1186/2049-6958-9-32

  56. Buonsenso D, Raffaelli F, Tamburrini E, Biasucci DG, Salvi S, Smargiassi A, et al. Clinical role of lung ultrasound for diagnosis and monitoring of COVID-19 pneumonia in pregnant women. Ultrasound Obstet Gynecol. 2020;56(1):106-9. doi:10.1002/uog.22055

  57. Yassa M, Birol P, Mutlu AM, Tekin AB, Sandal K, Tug N. Lung Ultrasound Can Influence the Clinical Treatment of Pregnant Women With COVID-19. J Ultrasound Med. 2021;40(1):191-203. doi:10.1002/jum.15367

  58. Youssef A, Serra C, Pilu G. Lung ultrasound in the coronavirus disease 2019 pandemic: a practical guide for obstetricians and gynecologists. Am J Obstet Gynecol. 2020;223(1):128-31. doi:10.1016/j.ajog.2020.05.014

  59. Oxford-Horrey C SM, Prabhu M, Abramovitz S, Griffin K, LaFond E, Riley L, Easter S. Putting It All Together: Clinical Considerations in the Care of Critically Ill Obstetric Patients with COVID-19. Am J Perinatol. 2020;37:1044-51. doi:10.1055/s-0040-1713121

  60. Griffin DO, Brennan-Rieder D, Ngo B, Kory P, Confalonieri M, Shapiro L, et al. The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021;23(1):40-7. doi:10.24875/AIDSRev.200001261

  61. Trahan M MI, Mitric C, Simard C, Lipes J, Abenhaim H. Severe and critical COVID-19 in pregnancy: A case series from Montreal. Obstetric Medicine. 2021. doi:10.1177/1753495X21990213

  62. Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, et al. A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics). Int J Gynaecol Obstet. 2021;154 Suppl 1:3-31. doi:10.1002/ijgo.13763

  63. Gavillet M RD, Hoffman M, Panchaud A, Baud D. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19? Ultrasound Obstet Gynecol. 2020;55:843-4. doi:10.1002/uog.22063

  64. The Joint Commission. Preventing maternal death. Sentinel Event Alert. 2010;44:1-4. https://psnet.ahrq.gov/issue/preventing-maternal-death

  65. Mhyre J DOR, Hameed A, Lappen J, Holley S, Hunter S, et al. The maternal early warning criteria: a proposal from the national partnership for maternal safety. Obstet Gynecol. 2014;124:782-6. doi:10.1097/AOG.0000000000000480

  66. Friedman AM, Campbell ML, Kline CR, Wiesner S, D'Alton ME, Shields LE. Implementing Obstetric Early Warning Systems. AJP Rep. 2018;8(2):e79-e84. doi:10.1055/s-0038-1641569

  67. Shields LEWS, Klein C, Pelletreau B, Hedriana H. Use of Maternal Early Warning Trigger tool reduces maternal morbidity. Am J Obstet Gynecol. 2016:1.e-.e6. doi:10.1016/j.ajog.2016.01.154

  68. Jiang J, Yang J, Mei J, Jin Y, Lu Y. Head-to-head comparison of qSOFA and SIRS criteria in predicting the mortality of infected patients in the emergency department: a meta-analysis. Scand J Trauma Resusc Emerg Med. 2018;26(1):56. doi:10.1186/s13049-018-0527-9

  69. Rose CH, Wyatt MA, Narang K, Lorenz KE, Szymanski LM, Vaught AJ. Timing of delivery with coronavirus disease 2019 pneumonia requiring intensive care unit admission. Am J Obstet Gynecol MFM. 2021;3(4):100373. doi:10.1016/j.ajogmf.2021.100373

  70. Bowyer L, Robinson HL, Barrett H, Crozier TM, Giles M, Idel I, et al. SOMANZ guidelines for the investigation and management sepsis in pregnancy. Aust N Z J Obstet Gynaecol. 2017;57(5):540-51. doi:10.1111/ajo.12646

  71. Deloya-Tomas E M-LT, Guerrero-Gutierrez M, Lopez-Fermin J, Perez-Nieto O, Carrion-Moya J, et al. . Considerations for Mechanical Ventilation in the Critically Ill Obstetric Patient. iMedPub Journals. 2020;6:1-8. doi:10.36648/2471-9803.6.4.10

  72. Pozos-Cortes K D-TE, Perez-Nieto O, Miranda C, Gonzalez R, Diaz C, et al. . Sindrome de dificultad respiratoria aguda severo en el embarazo. Revision de la literatura y reporte de dos casos. Med Crit. 2019;33:209-14.

  73. Pacheco L SA, Saade G. Early Acute Respiratory Support for Pregnant Patients with Coronavirus Disease 2019 (COVID-19) Infection. Obstet Gynecol 2020;136:42-5. doi:10.1097/AOG.0000000000003929

  74. Mellado-Artigas R FB, Angriman F, Hernandez-Sanz M, Arruti E, Torres A, et al. High-flow nasal oxygen in patients with COVID-19 associated acute respiratory failure. Crit Care. 2021;25:1-10. doi:10.1186/s13054-021-03469-w

  75. Elharrar X TY, Dols A. Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure. JAMA. 2020;323:2336-8. doi:10.1001/jama.2020.8255

  76. Gattinoni L, Busana M, Giosa L, Macri MM, Quintel M. Prone Positioning in Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med. 2019;40(1):94-100. doi:10.1055/s-0039-1685180

  77. Gattinoni L, Taccone P, Carlesso E, Marini JJ. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med. 2013;188(11):1286-93. doi:10.1164/rccm.201308-1532CI

  78. Testani E, Twiehaus S, Waters T, Pombar X. Conscious prone positioning in a pregnant patient with COVID-19 respiratory distress: A case report and review. Case Rep Womens Health. 2021;31:e00339. doi:10.1016/j.crwh.2021.e00339

  79. Society of Maternal Fetal Medicine. Management Considerations for Pregnant Patients with COVID-19 2021 [Disponible en: https://s3.amazonaws.com/cdn.smfm.org/media/2734/SMFM_COVID_Management_of_COVID_pos_preg_patients_2-2-21_(final).pdf.

  80. Perez-Nieto O E-MD, Guerrero-Gutierrez M, Zamarron-Lopez E, Mancilla-Galindo J, Kammar-Garcia A, et al. . Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study. Eur Respir J. 2021. doi:10.1183/13993003.00265-2021

  81. Halscott T VJatSC-TF. Management Considerations for Pregnant Patients With COVID-19 2021. https://s3.amazonaws.com/cdn.smfm.org/media/2734/SMFM_COVID_Management_of_COVID_pos_preg_patients_2-2-21_(final).pdf.

  82. Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ. 2016;355:i5044. doi:10.1136/bmj.i5044

  83. Raikkonen K GM, Kajantie E. Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children. JAMA. 2020;323:1924-33. doi:10.1001/jama.2020.3937

  84. Rodriguez A, Wang Y, Ali Khan A, Cartwright R, Gissler M, Jarvelin MR. Antenatal corticosteroid therapy (ACT) and size at birth: A population-based analysis using the Finnish Medical Birth Register. PLoS Med. 2019;16(2):e1002746. doi:10.1371/journal.pmed.1002746

  85. Fowden AL, Forhead AJ. Glucocorticoids as regulatory signals during intrauterine development. Exp Physiol. 2015;100(12):1477-87. doi:10.1113/EP085212

  86. Solano ME, Arck PC. Steroids, Pregnancy and Fetal Development. Front Immunol. 2019;10:3017. doi:10.3389/fimmu.2019.03017

  87. Saad A CL, Saade G, Pacheco L. Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19). Obstet Gynecol. 2020;136:823-6. doi:10.1097/AOG.0000000000004103

  88. Ssekandi A SQ, Olal E, Kawuki J, Adam M. Corticosteroids use in pregnant women with covid-19: Recommendations from available evidence. J Multidiscip Healthc. 2021;14:659-63. doi:10.2147/JMDH.S301255

  89. Recovery Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704. doi: 10.1056/NEJMoa2021436

  90. Bhimraj A MR, Shumaker A, Lavergne V, Baden L, Chi-Chung Cheng V. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 2021 [updated 14 September 2021. Disponibile en: https://www.idsociety.org/globalassets/idsa/practice-guidelines/covid-19/treatment/idsa-covid-19-gl-tx-and-mgmt-v5.1.2.pdf.

  91. Jimenez-Lozano C-TJ, Fernandez-Hidalgo N, Miarons M, Frick M, Batllori E, et al. . Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study. J Clin Pharm Ther. 2021;46:1062-70. doi:10.1111/jcpt.13394

  92. Lamontagne F, Agoritsas T, Siemieniuk R, Rochwerg B, Bartoszko J, Askie L, et al. A living WHO guideline on drugs to prevent covid-19. BMJ. 2021;372:n526. doi:10.1136/bmj.n526

  93. Jorgensen S DM, Lapinsky S. A review of remdesivir for COVID-19 in pregnancy and lactation. J Antimicrob Chemother. 2021:1-8. doi:10.1093/jac/dkab311

  94. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines 2021 [Disponible en: https://covid19treatmentguidelines.nih.gov/.

  95. ACOG Practice Bulletin, Number 229. Obstet Gynecol. 2021;137(6):e116-e27. doi:10.1097/AOG.0000000000004410.

  96. Gracia-Perez-Bonfils A, Martinez-Perez O, Llurba E, Chandraharan E. Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection. Eur J Obstet Gynecol Reprod Biol. 2020;252:286-93. doi:10.1016/j.ejogrb.2020.06.049

  97. Sinaci S OD, Tokalioglu E,Ozturk F, Senel S. Cardiotocographic features in COVID-19 infected pregnant women. J Perinat Med. 2021:1-10. doi:10.1515/jpm-2021-0132

  98. Tolcher M MJ, Eppes C, Muigai D, Shamshirsaz A, Guntupalli K, et al. Prone positioning for pregnant women with hypoxemia due to coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2020;136:259-61. doi:10.1097/AOG.0000000000004012

  99. Perez-Nieto O Z-LE, Deloya-Tomas E, Soriano R, Sanchez S. Manual Basico Ventilacion Mecanica para Areas Criticas Grupo AVENTHO2019.

  100. Pacheco L SG, Hankins G. Mechanical ventilation during pregnancy: Sedation, analgesia and paralysis. Clin Obstet Gynecol 2014;57:844-50. doi: 10.1097/GRF.0000000000000064

  101. Kostelecky N PS. Drugs in Pregnancy. In: Oropello JM, Pastores SM, Kvetan V,. Critical Care: McGraw Hill; 2021.

  102. FDA. Fentanyl Citrate Injection, USP 2013 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/016619s034lbl.pdf.]

  103. FDA. Etomidate Injection 2001 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/018227_S012_AMIDATE_PRNTLBL.pdf.]

  104. FDA. Remifentanil hydrochloride 2004 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20630se5-005_ultiva_lbl.pdf.]

  105. FDA. Midazolam Injection 2017 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208878Orig1s000lbl.pdf.]

  106. FDA. Propofol Injectable Emulsion. 2014.

  107. FDA. Dexmetomidine hydrochloride 2020 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021038Orig1s035lbl.pdf.]

  108. FDA. Vecuronium Bromide for Injection 2010 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/075549s009lbl.pdf.]

  109. FDA. Cisatracurium besylate injection 2010 [Disponible en: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020551s019lbl.pdf.]

  110. Tambawala Z HZ, Hamza L, Al Rayes M. Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy. BMJ Case Rep. 2021;14. doi:10.1136/bcr-2020-240823

  111. Rahman N JN, Annuar N, Rahman R, Murad A, El-Enshasy, Illias R Efficient substrate accesibility of cross-linked levanase aggregates using dialdehyde starch as a macromolecular cross-linker. Carbohydrate Polymers 2021;267. doi: 10.1016/j.carbpol.2021.118159

  112. Beigel J TK, Dodd L, Mehta A, Zingman B, Kalil A, et al. Remdesivir for the Treatment of COVID-19 Final Report. N Engl J Med. 2020;383:1813-26. doi:10.1056/NEJMoa2007764

  113. Kotlyar AM, Tal O, Tal R. Vertical transmission of coronavirus disease 2019, a response. Am J Obstet Gynecol. 2021;224(3):329-30. doi:10.1016/j.ajog.2020.11.017

  114. Shanes E ML, Otero S, Azad H, Miller E, Goldstein J. Placental Pathology in Covid-19. Am J Clin Pathol. 2020;154:23-32. doi:10.1093/ajcp/aqaa089

  115. Vivanti A V-FC, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nature Communications. 2020;11:1-7. doi:10.1038/s41467-020-17436-6

  116. J F. Trauma in pregnancy. Top Emerg Med. 1985;7:51-7.

  117. Kadiwar S SJ, Ledot S, Johnson M, Bianchi P, Singh N, et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet. 2021;397:1539-40. doi:10.1016/S0140-6736(21)00716-9

  118. Pierce-Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020;2(3):100134. doi:10.1016/j.ajogmf.2020.100134

  119. Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS, et al. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1355-9. doi:10.15585/mmwr.mm6938e2

  120. Society for Maternal-Fetal Medicine and Society for Obstetric and Anesthesia and Perinatology Labor and Delivery COVID-19 Considerations 2020 [Disponible en: https://s3.amazonaws.com/cdn.smfm.org/media/2327/SMFM-SOAP_COVID_LD_Considerations_-_revision_4-14-20_-_changes_highlighted.pdf.

  121. Flaherman VJ, Afshar Y, Boscardin J, Keller RL, Mardy A, Prahl MK, et al. Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa1411

  122. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):637-45. doi:10.1001/jama.299.6.637

  123. Committee Opinion No. 713: Antenatal corcisteroid therapy for fetal maturation. Obstet Gynecol. 2017;130:e102-9. doi:10.1097/AOG.0000000000002237

  124. Stefanovic V. COVID-19 infection during pregnancy: fetus as a patient deserves more attention. J Perinat Med. 2020;48(5):438-40. doi:10.1515/jpm-2020-0181

  125. Sankaran D, Nakra N, Cheema R, Blumberg D, Lakshminrusimha S. Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update. Neoreviews. 2021;22(5):e284-e95. doi:10.1542/neo.22-5-e1001

  126. Zhu F, Zozaya C, Zhou Q, De Castro C, Shah PS. SARS-CoV-2 genome and antibodies in breastmilk: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2021;106(5):514-21. doi:10.1136/archdischild-2020-321074

  127. Jamieson DJ, Rasmussen SA. Protecting Pregnant Women and Their Infants From COVID-19: Clues From Maternal Viral Loads, Antibody Responses, and Placentas. JAMA Netw Open. 2020;3(12):e2030564. doi:10.1001/jamanetworkopen.2020.30564

  128. Medina-Jimenez V, Bermudez-Rojas ML, Murillo-Bargas H, Rivera-Camarillo AC, Munoz-Acosta J, Ramirez-Abarca TG, et al. The impact of the COVID-19 pandemic on depression and stress levels in pregnant women: a national survey during the COVID-19 pandemic in Mexico. J Matern Fetal Neonatal Med. 2020:1-3. doi:10.1080/14767058.2020.1851675

  129. Conde-Agudelo ARR. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021:1-69. doi:10.1016/j.ajog.2021.07.009

  130. Valdespino-Vazquez MY, Helguera-Repetto CA, Leon-Juarez M, Villavicencio-Carrisoza O, Flores-Pliego A, Moreno-Verduzco ER, et al. Fetal and placental infection with SARS-CoV-2 in early pregnancy. J Med Virol. 2021;93(7):4480-7. doi:10.1002/jmv.26965

  131. Di Mascio D, Buca D, Berghella V, Khalil A, Rizzo G, Odibo A, et al. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Ultrasound Obstet Gynecol. 2021;57(5):687-97. doi:10.1002/uog.23628

  132. Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020;12(2). doi:10.3390/v12020194

  133. Duppers AL, Bohnhorst B, Bultmann E, Schulz T, Higgins-Wood L, von Kaisenberg CS. Severe fetal brain damage subsequent to acute maternal hypoxemic deterioration in COVID-19. Ultrasound Obstet Gynecol. 2021;58(3):490-1. doi:10.1002/uog.23744

  134. Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi:10.1136/bmj.m3026

  135. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-8. doi:10.15585/mmwr.mm6930e1

  136. Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5. doi:10.1001/jama.2020.12603

  137. Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949-59. doi:10.1136/bjsports-2020-102596

  138. Rehabilitation in the wake of COVID-19 A Phoenix from the ashes. British Society of Rehabilitation Medicine 2020 [1-19]. [Disponible en: https://www.bsrm.org.uk/downloads/covid-19bsrmissue1-published-27-4-2020.pdf.]

  139. Selvaraj V, Dapaah-Afriyie K. Lung cavitation due to COVID-19 pneumonia. BMJ Case Rep. 2020;13(7). doi:10.1136/bcr-2020-237245

  140. Chen W TY, Li Z, Zhu J, Wei T, Lei J. Potential Interaction Between SARS CoV2 and Thyroid: A Review. Endocrinology. 2021;162:1-13. doi:10.1210/endocr/bqab004

  141. Andrade B SS, Rodrigues-de-Assis-Soares W, Souza-Rangel F, Oliveira-Santos N, Santos-Freitas A, et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses. 2021;13:1-24. doi:10.3390/v13040700

  142. Gonzalez J, Benitez ID, Carmona P, Santisteve S, Monge A, Moncusi-Moix A, et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest. 2021;160(1):187-98. doi:10.1016/j.chest.2021.02.062

  143. Caring for adult patients with post-Covid19 conditions. RACGP 2020 [Disponible en: https://www.racgp.org.au/FSDEDEV/media/documents/RACGP/Coronavirus/Post-COVID-19-conditions.pdf]

  144. Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force. Eur Respir J. 2020. doi:10.1183/13993003.02197-202

  145. Haddad LB, RamaRao S, Hazra A, Birungi H, Sailer J. Addressing contraceptive needs exacerbated by COVID-19: A call for increasing choice and access to self-managed methods. Contraception. 2021;103(6):377-9. doi:10.1016/j.contraception.2021.03.023

  146. Miller HE, Henkel A, Leonard SA, Miller SE, Tran L, Bianco K, et al. The impact of the COVID-19 pandemic on postpartum contraception planning. Am J Obstet Gynecol MFM. 2021;3(5):100412. doi:10.1016/j.ajogmf.2021.100412

  147. Krishna UR. Reproductive Health During the COVID-19 Pandemic. J Obstet Gynaecol India. 2021:1-5. doi:10.1007/s13224-021-01546-2

  148. Benson L MT, Tarleton J, Micks E. Society of Family Planning interim clinical recommendations: Contraceptive provision when healthcare access is restricted due to pandemic response 2020 [Disponible en: https://www.nationalfamilyplanning.org/file/documents---service-delivery-tools/SFP-Interim-Recommendations-Contraception-and-COVID-19_05.28.2020.pdf.]




2020     |     www.medigraphic.com